Current prognostic criteria for colorectal cancer are not entirely satisfactory; the TNM classification' is complex, modifications of Dukes's classification2 have led to confusion, while Jass' classification3 is poorly reproducible.4 Combining these with assessments of tumour behaviour, such as DNA content,5 might result in a better prediction of prognosis. Generally, two techniques have been developed for the cytological measurement of nuclear DNA content. Early reports measuring DNA content from section preparations using light microscopy (densitometry) proved promising,6 but cumbersome. 7 Emphasis therefore shifted to flow cytometry, in which large numbers of cells can be rapidly analysed for their nuclear DNA content. Flow cytometry, however, may fail to detect small numbers of aneuploid tumour cells, containing abnormal amounts of DNA, if most of the specimen contains cells with normal (near diploid) DNA content. Consequently, flow cytometric studies assessing the independent prognostic value of tumour DNA content in colorectal cancer are conflicting, some reports implying that it is of major prognostic importance, [8] [9] [10] [11] [12] [13] others that it is of little value relative to Dukes's stage. 11 '9 In contrast with flow cytometry, DNA densitometry, determining the DNA content of small numbers of tumour cells from stained microscope sections, is potentially more specific. DNA content assessed by this technique is claimed to be related to survival in several tumours,2025 including colorectal cancer. 26 The prognostic value of densitometry in colorectal cancer, however, requires verification in a larger series of cases. A study was therefore performed to establish the role of nuclear DNA content, as determined by DNA By convention, DNA aneuploidy may also be expressed as the proportion of cells with values above Sc (the Sc exceeding rate). Similarly, the more abnormal the DNA content, the greater the number of cells that deviate from the 2c value (-that is, the greater the 2c deviation index). In addition to these assessments of DNA content, mean nuclear area was derived for each section (Table I ). All analyses were performed for both the mean and maximum values of each variable per case.
In accordance with the clonal concept of tumour development, the ploidy state of the entire tumour was taken as that of the most aneuploid specimen comprising that tumour. PILOT 
STUDIES
Nuclei sample size -Two sections were randomly chosen from each of 20 randomly selected cases and 50 tumour nuclei measured from each of three randomly selected fields per section.
Analysis of variance for a nested design determined the components of variance from nucleus to nucleus within a field, from field to field within a section, and from section to section within a subject. The numbers of nuclei, fields, and sections that gave a subject mean with the greatest precision (-that is, the lowest standard error) were then calculated to give the number of nuclei which should be measured per section. 32 Well and poorly differentiated tissue -A study was performed to determine if DNA densitometry differs significantly between well and poorly differentiated colorectal tumour mucosa. Twenty five cases in which three independent observers identified the tumour as being uniformly well differentiated were randomly selected and compared with a similar number of uniformly poorly differentiated tumours, using found that flow cytometry was not of prognostic value in colorectal cancer. Therefore, both flow cytometric, and potentially more specific densitometric studies, suggest that DNA content is of little prognostic benefit in relation to currently accepted criteria in colorectal cancer. It therefore seems unlikely that DNA analysis using densitometric or flow cytometric methods will play a significant prognostic part in the management of colorectal cancer patients, probably because they can only detect comparatively large changes in tumour DNA content. Densitometry may yet prove of benefit in the diagnosis of premalignant conditions,55-58 because its morphometric features may be used interactively to classify any given cell and therefore replace large numbers of flow cytometric parameters. The future assessment of DNA content will probably lie in gene probes, which can detect changes in chromosome structure more subtly than DNA densitometry.9"I In the meantime, it seems that conventional histological variables remain the best predictors of prognosis in colorectal cancer.
